• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Emcure Pharmaceuticals Limited — Important, 11-07-2026: Sale or disposal

    11-07-2026 | 10:29 am

    Emcure's subsidiary, Gennova, sold its mRNA business for 139.5 Cr cash via slump sale to Immunoscript Life Science. This strategic move helps Gennova focus on core biotech products and biosimilars. The divested mRNA unit contributed 64.71 Cr revenue and 132.63 Cr net worth in FY26.

    No comments yet. Be the first to comment!

    All announcements from Emcure Pharmaceuticals Limited